Detalles de la búsqueda
1.
Fatal systemic angiomatosis with widespread sclerotic skeletal changes, diagnosed with the aid of a bone marrow biopsy: the lymphatics enter the bone marrow.
Pol J Pathol
; 69(3): 314-318, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30509059
2.
Clonal evolution in adult TCF3::HLF-positive acute lymphoblastic leukemia undergoing stem cell transplantation.
Ann Hematol
; 101(11): 2553-2554, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35907039
3.
Reduced-intensity conditioning allogeneic transplantation after salvage treatment with DT-PACE in myeloma patients relapsing early after autologous transplant.
Eur J Haematol
; 99(4): 300-305, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28632322
4.
COVID-19 in bone marrow transplant recipients: reflecting on a single centre experience.
Br J Haematol
; 190(2): e67-e70, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32469077
5.
Management of Allogeneic Stem Cell Transplantation for High-Risk AML following SARS-CoV-2 Associated Pancytopenia with Marked Bone Marrow Biopsy Alterations.
Case Rep Hematol
; 2021: 8843063, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33510919
6.
Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies.
Ann Hematol
; 89(11): 1141-5, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20544351
7.
Autoimmune Cytopenias Developing Late Post Alemtuzumab-Based Allogeneic Stem Cell Transplantation: Presentation of Short Case Series from a Transplant Center.
Cell Transplant
; 29: 963689720950641, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32806929
8.
First case of near haploid philadelphia negative B-Cell acute lymphoblastic leukaemia relapsing as acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
Leuk Res Rep
; 14: 100213, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32612922
9.
A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant.
Hematol Rep
; 11(1): 7800, 2019 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30915202
10.
The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.
Biol Blood Marrow Transplant
; 14(11): 1288-97, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18940684
11.
A continuous mental task decreases the physiological response to soccer-specific intermittent exercise.
Br J Sports Med
; 41(12): 908-13, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17517858
12.
Adenoviral Subacute Focal Meningoencephalitis Complicating Polatuzumab, Bendamustine and Rituximab Chemo-Immunotherapy for Aggressive B-Cell Lymphoma.
Indian J Hematol Blood Transfus
; 38(1): 184-186, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35125728
13.
The tumor kinetics of multiple myeloma following autologous stem cell transplantation as assessed by measuring serum-free light chains.
Leuk Lymphoma
; 47(1): 21-8, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16321823
14.
Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting.
Blood Adv
; 5(21): 4500-4503, 2021 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34614515
15.
ERRATUM: A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant.
Hematol Rep
; 12(2): 8995, 2020 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33282167
16.
Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation.
Leuk Lymphoma
; 61(1): 202-205, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31402762
17.
Reduced intensity allogeneic stem cell transplant for treatment of blastic plasmacytoid dendritic cell neoplasm.
Hematol Rep
; 6(1): 5119, 2014 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-24711917
18.
Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma: reflections on a single center experience.
Leuk Lymphoma
; 60(12): 3075-3077, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31079514
19.
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study.
Blood
; 107(4): 1724-30, 2006 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16239425
20.
Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival.
Br J Haematol
; 130(4): 542-8, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16098068